Trends in Antihyperglycemic Medication Prescriptions and Hypoglycemia in Older Adults: 2002-2013

PloS One
Kristin K ClemensAmit X Garg

Abstract

Over the last decade, several new antihyperglycemic medications have been introduced including those associated with a lower hypoglycemia risk. We aimed to investigate how these medications are being prescribed to older adults in our region. We conducted population-based cross-sectional analyses of older adults (mean age 75 years) with treated diabetes in Ontario, Canada from 2002 until 2013, to examine the percentage prescribed insulin, sulphonylureas, alpha-glucosidase inhibitors, metformin, thiazolidinediones, meglitinides, and dipeptidyl peptidase-4 inhibitors. Over the study period, we also examined their hospital encounters for hypoglycemia (emergency room or inpatient encounter). The mean age of treated patients increased slightly over the study quarters and the proportion that were women declined. With the exception of chronic kidney disease, cancer, dementia, and neuropathy, the percentage with a comorbidity appeared to decline. The percentage of treated patients prescribed metformin, gliclazide and dipeptidyl peptidase-4 inhibitors increased as did combination therapy. Glyburide and thiazolidinedione prescriptions declined, and insulin use remained stable. In those with newly treated diabetes, the majority were prescr...Continue Reading

References

Jun 1, 1997·Journal of Clinical Epidemiology·T van StaaJ Monette
Jun 6, 2002·Diabetes, Obesity & Metabolism·A J GarberUNKNOWN Glyburide/Metformin Initial Therapy Study Group
Sep 13, 2007·JAMA : the Journal of the American Medical Association·A Michael LincoffSteven E Nissen
Dec 13, 2007·JAMA : the Journal of the American Medical Association·Lorraine L LipscombeDavid A Alter
Jan 29, 2008·Diabetes Care·Steven E KahnUNKNOWN Diabetes Outcome Progression Trial (ADOPT) Study Group
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Jul 22, 2009·Pharmacoepidemiology and Drug Safety·Kristian B FilionJames M Brophy
Jan 28, 2010·Diabetes Care·Andrew CohenG Caleb Alexander
Feb 18, 2011·Current Medical Research and Opinion·Jean DoucetJulio Rosenstock
May 31, 2011·Diabetes Research and Clinical Practice·Marta BavieraMaria Carla Roncaglioni
Feb 22, 2012·The American Journal of Medicine·Nihar R DesaiNiteesh K Choudhry
Apr 17, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·P D FosterT Gomes
Sep 10, 2013·Irish Journal of Medical Science·N L ZaharanK Bennett
Mar 14, 2014·Diabetes Care·Christian HamppDiane K Wysowski
Jul 26, 2014·BMJ Open·David N JuurlinkUNKNOWN Canadian Drug Safety and Effectiveness Research Network (CDSERN)
Apr 1, 2013·Journal of American College Health : J of ACH·Craig W Trumbo, Raquel Harper

❮ Previous
Next ❯

Citations

Apr 15, 2016·Current Diabetes Reports·Vishal Ahuja, Chia-Hung Chou
Jun 3, 2017·Fundamental & Clinical Pharmacology·Mickael ArnaudFrancesco Salvo
Dec 21, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Abdallah Y NaserLi Wei
Aug 12, 2017·JBI Database of Systematic Reviews and Implementation Reports·Jared M CampbellEdoardo Aromataris
Aug 20, 2020·The International Journal of Pharmacy Practice·Thananan Rattanachotphanit, Onanong Waleekhachonloet
Jan 11, 2020·Endocrinology, Diabetes & Metabolism·Kristy IglayKamlesh Khunti
Aug 29, 2016·European Journal of Clinical Pharmacology·J MoonR O Day
Aug 29, 2018·Journal of Alzheimer's Disease : JAD·Jared M CampbellEdoardo Aromataris
Aug 30, 2019·Pharmacoepidemiology and Drug Safety·Matthew H SecrestKristian B Filion
Nov 27, 2020·Clinical Journal of the American Society of Nephrology : CJASN·Flory T MuandaAmit X Garg
Nov 27, 2020·Diabetes Research and Clinical Practice·Domingo Orozco-BeltránConcepción Carratalá-Munuera
Mar 4, 2020·Archives of Gerontology and Geriatrics·Ming-Yueh ChouLiang-Kung Chen

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.